Statistical Tests of Contingent-Claims Asset-Pricing Models: A New Methodology
Journal of Financial Economics 17 (1986), 143-173
Business Models to Cure Rare Disease: A Case Study of Solid Biosciences
with Esther Kim, Journal of Investment Management 14(2016), 87–101.
Hedge Fund Holdings and Stock Market Efficiency
with Charles Cao, Bing Liang, and Lubomir Petrasek, Review of Asset Pricing Studies rax015 (2017)
Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology
with Vahid Montazerhodjat; Shomesh E. Chaudhuri; Daniel J. Sargent, JAMA Oncology (2017)
Spectral Analysis of Stock-Return Volatility, Correlation, and Beta
with Shomesh Chaudhuri, Signal Processing and Signal Processing Education Workshop (SP/SPE), 2015 IEEE, 232–236.
Health, Wealth, and the 21st Century Cures Act
with Tomas Philipson and Andrew von Eschenbach, JAMA Oncology 2(2016), 17–18.
TRC Networks and Systemic Risk
with Roger Stein, Journal of Alternative Investment 18(2016), 52–67.
The Wisdom of Twitter Crowds: Predicting Stock Market Reactions to FOMC Meetings via Twitter Feeds
with with Pablo D. Azar, Journal of Portfolio Management 42(2016), 123–134.
Q Group Panel Discussion: Looking to the Future
with Martin Leibowitz, Robert C. Merton, Stephen A. Ross, and Jeremy Siegel, Financial Analysts Journal
Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans
with Vahid Montazerhodjat and David M. Weinstock, Science Translational Medicine 8(2016), 327ps6.